Willow vs HealthRx: Structured tracking or lower-cost compounded plans
Willow vs HealthRx comes down to support model versus price and pharmacy approach. Early verdict: choose Willow for a structured telehealth program with progress tracking and follow-up; choose HealthRx if lower advertised entry pricing and compounded overnight cold shipping matter most.
Explore Willow’s tracking and follow-up
How these services differ at a glance
The comparison centers on four distinctive differences supported in the source: program model and follow-up, starting price and plan structure, compounded medication and regulatory status, and shipping and dose management.
Program model and patient support
Willow positions its offering as a “telehealth-first weight management program with wellness tracking and follow-up support.” The source describes Willow as a structured weight management journey emphasizing progress tracking and follow-up consultations and notes a licensed telehealth team. HealthRx, by contrast, emphasizes clinician review to decide whether semaglutide or tirzepatide is appropriate and frames the purchase as selecting a plan rather than a medication menu.
Starting price and plan details
Willow’s starting price is listed as 299. HealthRx lists lower advertised entry pricing: “$99 | /month | on a 12-month prepaid semaglutide plan ($1,163 today; $1,188 at renewal). Tirzepatide plans start at $179/month.” HealthRx also notes the lowest advertised monthly price requires a longer prepaid plan and that pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Compare Willow pricing options
Medication type and regulatory notes
Both sources include regulatory cautions about compounded medications. Willow states: “Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.” HealthRx states: “Compounded medication is not FDA-approved. It is prepared by a licensed pharmacy for an individual patient with a valid prescription” and also that compounded medication is prepared in a licensed 503A pharmacy cleanroom. HealthRx emphasizes that clinicians decide whether semaglutide or tirzepatide, or neither, is appropriate.
Shipping, dose changes and logistics
HealthRx lists “Overnight shipping | Cold chain, tracked, free on every plan” and notes dose adjustments and that “Your plan price does not change when your dose does.” Willow’s captured evidence does not verify shipping, fees, membership or cancellation details on the captured page.
| Criteria | Willow | HealthRx |
|---|---|---|
| Starting price | 299 | $99/month on a 12-month prepaid semaglutide plan; tirzepatide from $179/month |
| Program model | Telehealth-first program with progress tracking and follow-up consultations | Clinician-reviewed plan selection; clinician decides medication fit |
| Medication type | Oral GLP-1 program; compounded meds when offered (not FDA-approved) | Compounded semaglutide or tirzepatide prepared per prescription |
| Regulatory note | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. | Compounded medication is not FDA-approved; prepared in a licensed 503A pharmacy cleanroom |
| Shipping and logistics | Not verified on captured page | Overnight cold shipping; cold chain tracked and free on every plan |
| Support | Licensed telehealth team, progress tracking tools, follow-up consultations | Clinician review, dose adjustments, account and support noted |
Decision factors: detailed comparison
Support and long-term program design
Willow explicitly markets a structured journey with wellness tracking and follow-up meant to convert GLP-1 efficacy into longer-term outcomes, and lists a licensed telehealth team and progress tracking tools. HealthRx documents clinician review and ongoing dose adjustments but does not present the same structured progress-tracking emphasis in the captured evidence.
Price sensitivity and plan commitments
HealthRx advertises substantially lower entry pricing on a prepaid 12-month semaglutide plan and warns the lowest advertised monthly price requires a longer prepaid plan. Willow lists a higher starting price of 299 and notes higher monthly entry pricing for some plans in pros/cons captured evidence.
Compounded medication and safety notes
Both providers’ captured evidence includes regulatory language about compounded medications not being FDA-approved. HealthRx adds that compounded medication is prepared in a licensed 503A pharmacy cleanroom and reiterates that the clinician determines whether a medication is appropriate.
Review HealthRx shipping and plan terms
Final comparison and short conclusion
Willow vs HealthRx is a choice between Willow’s structured telehealth program with progress tracking and follow-up consultations and HealthRx’s lower advertised entry pricing, clinician-directed medication selection, compounded pharmacy model and overnight cold shipping. The primary keyword Willow vs HealthRx summarizes that tradeoff.
Choose Willow if…
You want a telehealth-first weight management program that emphasizes progress tracking, follow-up consultations, and a licensed telehealth team. Treatment is available only when a licensed clinician determines it is medically appropriate, and compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Choose HealthRx if…
You prioritize lower advertised starting pricing on a prepaid semaglutide plan, want clinician review to determine medication fit, need overnight cold shipping and accept compounded medication prepared per prescription with the regulatory limits noted in the source.